Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Solanum dulcamara
Vigne européenne utilisée en application topique pour les affections cutanées ; les alcaloïdes solaniques rendent l’usage interne risqué aux doses utilisées pour la peau.
Bittersweet Nightshade (Solanum dulcamara) is a European vine traditionally used topically for various skin conditions including eczema and psoriasis. Its primary active compounds include solanine, solamargine, solasonine, and dulcamarine, which contribute to its anti-inflammatory and keratolytic effects. Internal use is risky due to the presence of toxic solanine alkaloids, limiting its application to topical formulations under professional guidance.
The steroidal alkaloids (e.g., solanine) inhibit acetylcholinesterase and modulate prostaglandin synthesis, providing anti-inflammatory effects. Glycoalkaloids such as solamargine exhibit keratolytic activity by disrupting keratinocyte cell membranes, aiding in the treatment of hyperkeratotic conditions. Additionally, solasonine has been shown to induce apoptosis in certain cell lines, which may contribute to its traditional use for warts.
Vigne européenne utilisée en application topique pour les affections cutanées ; les alcaloïdes solaniques rendent l’usage interne risqué aux doses utilisées pour la peau.
Bittersweet Nightshade (Solanum dulcamara) is a European vine traditionally used topically for various skin conditions including eczema and psoriasis. Its primary active compounds include solanine, solamargine, solasonine, and dulcamarine, which contribute to its anti-inflammatory and keratolytic effects. Internal use is risky due to the presence of toxic solanine alkaloids, limiting its application to topical formulations under professional guidance.
The steroidal alkaloids (e.g., solanine) inhibit acetylcholinesterase and modulate prostaglandin synthesis, providing anti-inflammatory effects. Glycoalkaloids such as solamargine exhibit keratolytic activity by disrupting keratinocyte cell membranes, aiding in the treatment of hyperkeratotic conditions. Additionally, solasonine has been shown to induce apoptosis in certain cell lines, which may contribute to its traditional use for warts.